Position in PTN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$209,131
-$113,173 QoQ
Shares Held
19,382
+4.8% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 26 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. PTN ranks #397 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in PTN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $209,131 | 19,382 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $322,304 | 18,502 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $272,317 | 17,706 | Shares | Defined | 2026-02-09 | |
| 2025-03-31 | $149,367 | 257,532 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $211,514 | 190,554 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $161,718 | 181,706 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $262,582 | 134,658 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $220,959 | 118,160 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $374,709 | 94,148 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $120,186 | 79,594 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $139,185 | 66,279 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $182,267 | 66,279 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $169,674 | 66,279 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $414,826 | 70,072 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $490,535 | 1,751,912 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $778,119 | 1,691,564 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $850,561 | 1,667,767 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $726,816 | 1,651,856 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,007,632 | 1,651,856 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,139,780 | 1,651,856 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,069,155 | 1,572,287 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $738,974 | 1,572,287 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $802,451 | 1,573,435 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,206,515 | 2,872,656 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||